Most cosmetic brands want the same thing: faster launches, lower costs and stronger claims. But there is a costly mistake: choosing the cheapest available test and expecting it to support the biggest possible promise. The problem is not cheap testing. It is expecting evidence built for screening to prove outcomes it was never designed to measure.